McKinsey: China's personal beauty industry is recovering fast
McKinsey believes that although the impact of the 2020 epidemic on the economy is more serious than distortion of any recession, it must be pointed out that the beauty industry will recover more than other industries. Its latest data and observations show that in February, China's personal beauty and beauty industry initially recorded an 80% decline, but in March, China's personal beauty and beauty industry fell by 20%, showing a very fast recovery trend. In mid-to-late April, McKinsey's survey of Chinese consumers showed that Chinese consumers expected to increase spending on daily necessities, personal care products, skin care products, or cosmetics in the next two weeks, and reduce spending on clothing.
2026-10-24
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
From “Made in China” to “Created in China”
-
COSMOPROF WORLDWIDE BOLOGNA PRESENTS “THE INVISIBLE BEAUTY”, THE PROJECT REVEALING WHAT MAKES BEAUTY POSSIBLE
-
Skin longevity, biotech, fragrance and sensory beauty take centre stage as in-cosmetics Asia returns to Bangkok
-
Skin longevity, biotech, fragrance and sensory beauty take centre stage as in-cosmetics Asia returns to Bangkok
-
South Korea to Impose Anti-Dumping Duties on Caustic Soda: Chinese Mainland Firms Face Up to 22.21%, Taiwan Region 38.89%
-
EAEU Initiates Review of Anti-Dumping Measures on Chinese Titanium Dioxide, Suspends Duties During Investigation
-
Three Major Indian Chemical Investments Target China's PC Exports
-
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
COSMOPROF WORLDWIDE BOLOGNA ANNOUNCES 2027 DATES AND UNVEILS A NEW LAYOUT FOR ITS 60TH ANNIVERSARY EDITION
-
South Korea Initiates Anti-Dumping Probe on Chinese PVC Suspension Resin, Involving Tianjin Bohua and Wanhua Chemical
Recommend Reading
-
Cipla CEO Calls Tirzepatide a High-Science Product with Strong Market Outlook
-
Pfizer Seen Holding Strategic Edge in Bidding Battle for Metsera
-
Novo Nordisk Enters High-Stakes Bidding War with Pfizer for Metsera
-
Merck and Eisai Halt Late-Stage Trial for Liver Cancer Therapy
-
LB Group Accelerates Overseas Investment: Securing Mines in Western Australia and Building a Plant in Malaysia
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
Premium Global Chemical Sourcing Requests (24-27Sep.,2026)
-
China’s 15th Five-Year Plan Sets New Priorities for Pharmaceutical Innovation and Supply Chains
-
Business Society September 28, 2026 Palm Oil Trend Analysis: Uptrend Confirmed
-
Business Society September 28, 2026 Polyester Staple Fiber Trend Analysis: Volatility